BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

LEE-CHENG, LIU


Session 4 – ADC Drug development and manufacturing trends challenges and solutions

Date:24 July (Wednesday)
Time14:10 – 14:15, 15:15– 15:40 (GMT+8)

LEE-CHENG, LIU

Founder, Chairman &President
EirGenix Inc.

​​

​​

For EirGenix Inc., health is important for all people. Under this belief, EirGenix established two business units to achieve the goal. One is contract development and manufacturing operation unit where EirGenix helps clients to manufacture their biologics; the other is the product development operation unit where we hope to fully apply our team's experience and knowledge on biologics from biosimilars, biobetters to new drugs. EirGenix's goal is that every patient can afford high-quality biopharmaceutical drugs.

Speech title & Synopsis

Opening Remarks,
Panel Discussion

.

​​